Literature DB >> 1551335

Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.

T King1, W Biddle, P Bhatia, J Moore, P B Miner.   

Abstract

We examined the distribution of colonic mucosal mast cells in 25 patients with active ulcerative colitis, with a clear line of demarcation separating active inflammation from normal mucosa. Biopsies, at least one adjacent to the line of demarcation, one in inflamed mucosa, and one above were obtained during colonoscopy. Eight patients had elevated mast cells throughout the colon, and 12 had increased numbers at the line of demarcation of disease. Mean numbers of mast cells from these patients were 6.3 (+/- 2.1 SD) in active inflammation, 19.5 (+/- 7.1 SD) at the line of demarcation, and 15.8 (+/- 8.4 SD) in normal mucosa. Histologic inflammation decreased as mast cells increased. The accumulation of mast cells at the visible line of demarcation between normal and abnormal mucosa suggests mast cells play a critical role in either accelerating the process of inflammation or in suppressing continued extension of the disease.

Entities:  

Mesh:

Year:  1992        PMID: 1551335     DOI: 10.1007/bf01307568

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Mast cells in inflammatory conditions of the gastrointestinal tract.

Authors:  R B HIATT; L KATZ
Journal:  Am J Gastroenterol       Date:  1962-05       Impact factor: 10.864

2.  Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease.

Authors:  P Goldsmith; B McGarity; A F Walls; M K Church; G H Millward-Sadler; D A Robertson
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

3.  Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis.

Authors:  C A Baum; P Bhatia; P B Miner
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

4.  Ultrastructure of the ileum in Crohn's disease. Immune lesions and mastocytosis.

Authors:  P Ranlöv; M H Nielsen; J Wanstrup
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

5.  Crohn's disease--mast cell quantitation using one micron plastic sections for light microscopic study.

Authors:  A M Dvorak; R A Monahan
Journal:  Pathol Annu       Date:  1983

6.  5-Aminosalicylate: oxidation by activated leukocytes and protection of cultured cells from oxidative damage.

Authors:  B J Dull; K Salata; A Van Langenhove; P Goldman
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

7.  Altered inflammatory reaction in nonspecific ulcerative colitis.

Authors:  Z T Bercovitz; S C Sommers
Journal:  Arch Intern Med       Date:  1966-04

8.  Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis.

Authors:  F Dallegri; L Ottonello; A Ballestrero; F Bogliolo; F Ferrando; F Patrone
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

9.  Modulation of macrophage superoxide-induced cytochrome c reduction by mast cells.

Authors:  K N Dileepan; K M Simpson; D J Stechschulte
Journal:  J Lab Clin Med       Date:  1989-05

10.  Clinical efficacy of a new antiinflammatory drug with free radicals scavenging properties: superoxide dismutase (SOD) and catalase of human origin.

Authors:  G Szegli; A Herold; E Negut; N Bucurenci; E Mazilu; R Arion; D Dejica; L Turcanu; C Golea; I Sima
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1986 Jan-Mar
View more
  26 in total

1.  Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy.

Authors:  R Day; M Ilyas; P Daszak; I Talbot; A Forbes
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  The role of eosinophils in inflammatory bowel disease.

Authors:  S Al-Haddad; R H Riddell
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

Review 3.  Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation.

Authors:  Ashkan Farhadi; Jeremy-Z Fields; Ali Keshavarzian
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

4.  The role of mast cells in bacterial enteritis.

Authors:  Melanie A Sherman
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

5.  Distribution of mast cells in human ileocecal region.

Authors:  S Bacci; S Faussone-Pellegrini; B Mayer; P Romagnoli
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis.

Authors:  Christopher S Smillie; Moshe Biton; Jose Ordovas-Montanes; Keri M Sullivan; Grace Burgin; Daniel B Graham; Rebecca H Herbst; Noga Rogel; Michal Slyper; Julia Waldman; Malika Sud; Elizabeth Andrews; Gabriella Velonias; Adam L Haber; Karthik Jagadeesh; Sanja Vickovic; Junmei Yao; Christine Stevens; Danielle Dionne; Lan T Nguyen; Alexandra-Chloé Villani; Matan Hofree; Elizabeth A Creasey; Hailiang Huang; Orit Rozenblatt-Rosen; John J Garber; Hamed Khalili; A Nicole Desch; Mark J Daly; Ashwin N Ananthakrishnan; Alex K Shalek; Ramnik J Xavier; Aviv Regev
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

7.  Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease.

Authors:  S E Crowe; G K Luthra; M H Perdue
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

8.  Soluble CD14 is essential for lipopolysaccharide-dependent activation of human intestinal mast cells from macroscopically normal as well as Crohn's disease tissue.

Authors:  Sibylle A Brenner; Steffi Zacheja; Michael Schäffer; Katharina Feilhauer; Stephan C Bischoff; Axel Lorentz
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

9.  Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice.

Authors:  A Minocha; C Thomas; R Omar
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

10.  Role of histamine in a rat model of colitis.

Authors:  C M Gelbmann; K E Barrett
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.